crap [Two-Stage / GS Designs]

posted by d_labes  – Berlin, Germany, 2020-02-16 19:34 (455 d 03:08 ago) – Posting: # 21175
Views: 3,645

Dear Helmut,

» ...
»         Name Method Type  GMR power  alpha     TIE  ANVISA   comp delta
»          SLF      B    1 0.90   0.8 0.0272 0.04997 0.04999 higher  2E-5
»          SLF      B    1 0.90   0.9 0.0268 0.04985 0.04977  lower  8E-5
»       Potvin      B    1 0.95   0.8 0.0294 0.04876 0.04879 higher  3E-5
»   Potvin-SLF      B    1 0.95   0.8 0.0302 0.04999 0.05020 higher  2E-4
»     Fuglsang      B    1 0.95   0.9 0.0284 0.04960 0.04958  lower  2E-5
» Fuglsang-SLF      B    1 0.95   0.9 0.0286 0.04999 0.05032 higher  3E-4
»     Montague      D    2 0.90   0.8 0.0280 0.05180 0.05181 higher  1E-5
» Montague-SLF      D    2 0.90   0.8 0.0268 0.04998 0.04980  lower  2E-4
»     Fuglsang    C/D    2 0.90   0.9 0.0269 0.05021 0.05011  lower  1E-4
» Fuglsang-SLF    C/D    2 0.90   0.9 0.0266 0.04995 0.04967  lower  3E-4
»       Potvin      C    2 0.95   0.8 0.0294 0.05143 0.05136  lower  7E-5
»   Potvin-SLF      C    2 0.95   0.8 0.0282 0.05010 0.05010  equal
»     Fuglsang    C/D    2 0.95   0.9 0.0274 0.05010 0.05010  equal
» Fuglsang-SLF    C/D    2 0.95   0.9 0.0275 0.04962 0.04985 higher  2E-4
»
» TIE which is significantly >0.05 in red (limit of the binomial test 0.05036). I don’t understand why in some scenarios the TIE is lower with a minimum n2.
» Counterintuitive. :confused:

I'm quite sure: This is because of the simulation error. The differences of the TIE without and with min.n2 are so small. See the last column above.
Any try with a different seed of the random number generator may and will change the comparison.


Edit: Removed irrelevant columns for clarity. [Helmut]

Regards,

Detlew

Complete thread:

Activity
 Admin contact
21,462 posts in 4,487 threads, 1,514 registered users;
online 8 (0 registered, 8 guests [including 6 identified bots]).
Forum time: Sunday 23:42 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5